Quo Vadis Vaccine Research Trends of Coronavirus Disease-19 in Indonesia and Malaysia: A Bibliometric Analysis

Abstract

The Coronavirus Disease-19 (COVID-19) has become a centre of attention for several countries, including Indonesia and Malaysia. The two countries are trying to maintain the stability and security of each country from the impact that will be caused. The Indonesian and Malaysian governments decided to import vaccines from several countries to reduce the spread of the disease in the global community. However, to deal with the limitations of imported vaccines, Malaysia and Indonesia are conducting various studies related to COVID-19 vaccine research. This study will observe how Indonesia and Malaysia respond to vaccine research trends related to COVID-19 from 2020 to 2022. This study uses a qualitative descriptive method that is produced through bibliometric analysis to analyse data collected from Scopus. In addition, the authors also use several kinds of literature from reputable journals to add references and information related to the research. The results of the bibliometric analysis show that Malaysia has paid more attention to research publications related to COVID-19 than Indonesia. However, Indonesia has received official approval for its first vaccine since September 2021, while Malaysia is in the process of developing its own vaccine. The authors assume this is because Malaysia manages its own local vaccines, while Indonesia does the opposite.